Skip to main content

Table 1 Comparison of Demographics and Comorbidities of Patients With and Without SDs

From: Sleep disorders associated with risk of prostate cancer: a population-based cohort study

 

Sleep disorder (N = 41,444)

Control (N = 41,444)

P value

n

%

n

%

Age, year

    

0.58

  < 49

24,137

58.2

24,114

58.2

 

 50–64

9629

23.2

9597

23.2

 

  ≥ 65

7701

18.6

7710

18.6

 

Mean (SD) #

48.0

16.6

47.8

16.7

034

Occupation

    

0.65

 White collar

22,483

54.3

22,367

54.0

 

 Blue collar

14,250

34.4

14,377

34.7

 

 Others

4711

11.4

4700

11.3

 

Urbanization level

    

0.22

 1 (highest)

12,282

29.6

12,015

29.0

 

 2

12,417

30.0

12,472

30.1

 

 3

7350

17.7

7436

17.9

 

 4 (lowest)

9395

22.7

9521

23.0

 

Comorbidity

 Hyperlipidemia

7524

18.2

7630

18.4

0.34

 Diabetes

2187

5.28

2238

5.40

0.43

 Hypertension

12,345

29.8

12,459

30.1

0.39

 Urinary stones

2770

6.68

2868

6.92

0.18

 Urinary tract infection

3039

7.33

2796

6.75

0.001

Obesity

312

0.75

338

0.82

0.31

Anxiety

1775

4.28

1691

4.08

0.14

Depression

1187

2.86

1191

2.87

0.93

COPD

4939

11.9

5033

12.1

0.32

Alcohol-related illness

1573

3.80

1566

3.78

0.90

Medication

 Hypnotics

23,308

56.2

23,082

55.7

0.11

 Antihypertensives

11,657

28.1

11,748

28.4

0.48

PSA screening

5729

13.8

4523

10.9

< 0.001

  1. Chi-square test compared to total SD; #:t test; COPD: Chronic obstructive pulmonary disease
  2. : The urbanization level was categorized into 4 levels according to the population density of the residential area, with level 1 indicating the highest urbanization and level 4 indicating the lowest urbanization